Related Experiment Videos
Role of cholesterol in embryonic development
1Laboratoire d'Embryologie Pathologique Expérimentale, CHU Saint-Antoine, Paris, France. chroux@ccr.jussieu.fr
The American Journal of Clinical Nutrition
|May 9, 2000
Summary
Cholesterol synthesis inhibitors cause birth defects in rats, modeling Smith-Lemli-Opitz syndrome. This highlights cholesterol
Area of Science:
- Biochemistry
- Developmental Biology
- Genetics
Background:
- Distal inhibitors of cholesterol synthesis are teratogenic in rats.
- These inhibitors cause holoprosencephalic brain anomalies, and sometimes limb and genital malformations.
- The animal model closely resembles Smith-Lemli-Opitz syndrome, a genetic disorder.
Purpose of the Study:
- To investigate the teratogenic effects of cholesterol synthesis inhibitors in rats.
- To establish a potential animal model for Smith-Lemli-Opitz syndrome.
- To explore the role of cholesterol in embryonic development and its relation to the sonic hedgehog (Shh) gene.
Main Methods:
- Administration of AY 9944, BM 15766, and triparanol to rats.
- Gas chromatography-mass spectrometry (GC-MS) for sterol analysis.
- Comparison of animal model phenotypes and sterol profiles with human Smith-Lemli-Opitz syndrome patients.
Main Results:
- Inhibitors induced holoprosencephaly and other developmental anomalies in rats.
- GC-MS revealed hypocholesterolemia and precursor accumulation in treated rats.
- Sterol profiles in rats mirrored those in Smith-Lemli-Opitz syndrome patients, with 7-dehydrocholesterol accumulation.
Conclusions:
- The studied rat model accurately reflects Smith-Lemli-Opitz syndrome.
- Cholesterol is crucial for embryonic development, impacting Shh protein function.
- Further research is needed to clarify the precise link between Shh dysfunction and observed malformations.